Distinct discrepancy in breast cancer organoids recapitulation among molecular subtypes revealed by single-cell transcriptomes analysis

Ziqi Jia; Hengyi Xu; Yaru Zhang; Heng Cao; Chunyu Deng; Longchen Xu; Yuning Sun; Jiayi Li; Yansong Huang; Pengming Pu; Tongxuan Shang; Xiang Wang; Jianzhong Su; Jiaqi Liu

doi:10.1002/ctm2.70023

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (9) : e70023 DOI: 10.1002/ctm2.70023

LETTER TO THE JOURNAL

Distinct discrepancy in breast cancer organoids recapitulation among molecular subtypes revealed by single-cell transcriptomes analysis

Ziqi Jia ¹
, Hengyi Xu ²^,³
, Yaru Zhang ⁴
, Heng Cao ¹
, Chunyu Deng ⁴
, Longchen Xu ⁵
, Yuning Sun ⁶
, Jiayi Li ¹^,³
, Yansong Huang ¹^,³
, Pengming Pu ¹^,³
, Tongxuan Shang ¹^,³
, Xiang Wang ¹^,^†
, Jianzhong Su ⁴^,^†
, Jiaqi Liu ¹^,²^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Ziqi Jia, Hengyi Xu, Yaru Zhang, Heng Cao, Chunyu Deng, Longchen Xu, Yuning Sun, Jiayi Li, Yansong Huang, Pengming Pu, Tongxuan Shang, Xiang Wang, Jianzhong Su, Jiaqi Liu. Distinct discrepancy in breast cancer organoids recapitulation among molecular subtypes revealed by single-cell transcriptomes analysis. Clinical and Translational Medicine, 2024, 14(9): e70023 DOI:10.1002/ctm2.70023

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Pan B, Li X, Zhao D, et al. Optimizing individualized treatment strategy based on breast cancer organoid model. Clin Transl Med. 2021; 11(4): e380.

[2]	Wang R, Mao Y, Wang W, et al. Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis. Genome Biology. 2022; 23(1).

[3]	Chen P, Zhang X, Ding R, et al. Patient-derived organoids can guide personalized-therapies for patients with advanced breast cancer. Adv Sci. 2021; 8(22): 2101176. doi:10.1002/advs.202101176

[4]	Xu H, Jia Z, Liu F, et al. Biomarkers and experimental models for cancer immunology investigation. MedComm. 2023; 4(6): e437.

[5]	Sachs N, de Ligt J, Kopper O, et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell. 2018; 172(1-2): 373-386.

[6]	Parker JS, Mullins M, Cheang MCU, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. Journal of Clinical Oncology. 2009; 27(8): 1160-1167.

[7]	Ding S, Chen X, Shen K. Single-cell RNA sequencing in breast cancer: understanding tumor heterogeneity and paving roads to individualized therapy. Cancer Commun (Lond). 2020; 40(8): 329-344.

[8]	Abdullah LN, Chow EKH. Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med. 2013; 2(1): e3.

[9]	Osinsky S, Molls M, Horsman MR, Vaupel P. Tumour hypoxia in the clinical setting: conclusions. In: Osinsky S, Friess H, Vaupel P, eds. Tumor Hypoxia in the Clinical Setting. National Academy of Sciences; 2011: 265-268.

[10]	Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021; 22(6): bbab260.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.